Waldec Jorge David Filho

Waldec Jorge David Filho

Auto-generated profile, based on publicly available information

Waldec Jorge David Filho

Programa de Pós Graduação , Faculdade de Medicina do ABC , Santo André , SP , Brazil

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2005 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
RFRobson Ferrigno
Robson Ferrigno
RNRicardo Akiyoshi Nakamura
Ricardo Akiyoshi Nakamura
PNPaulo Eduardo Ribeiro Dos Santos Novaes
Paulo Eduardo Ribeiro Dos Santos Novaes
APAntônio Cássio Assis Pellizzon
Antônio Cássio Assis Pellizzon
MMMaria Aparecida Conte Maia
Maria Aparecida Conte Maia
ALAdemar Lopes
Ademar Lopes

1 April 2003 in Urology
Verified
Journal Article
Closed access
PDF file
GGGustavo Cardoso Guimarães
Gustavo Cardoso Guimarães
RSRicardo Rodrigues De Souza
Ricardo Rodrigues De Souza
AGAndréa Paiva Gadêlha Guimarães
Andréa Paiva Gadêlha Guimarães
WFWaldec David Filho
Waldec David Filho
NGNara Valeschka De Matos Granja
Nara Valeschka De Matos Granja
ALAdemar Lopes
Ademar Lopes

31 October 2005 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
SAS. Aguiar
S. Aguiar
ALA. Lopes
A. Lopes
FSF.A. Soares
F.A. Soares
MRMauro Rossi
Mauro Rossi
FFF.O. Ferreira
F.O. Ferreira
WFW.J.D. Filho
W.J.D. Filho

17 January 2019 in Einstein (São Paulo)
Verified
Journal Article
Open access
PDF file
LSLuana Carolina Ferreira Fiuza Silva
Luana Carolina Ferreira Fiuza Silva
LALilian Silva Martins de Arruda
Lilian Silva Martins de Arruda
WDWaldec Jorge David
Waldec Jorge David
FCFelipe José Silva Melo Cruz
Felipe José Silva Melo Cruz
DTDamila Cristina Trufelli
Damila Cristina Trufelli
AGAuro del Giglio
Auro del Giglio
To define a predictive factor for pathologic complete response, compare the oncologic outcomes associated with the degree of pathologic response after neoadjuvant chemotherapy, and to analyze pathologic complete response as a prognostic factor for overall survival and progression-free survival. A retrospective study of patients admitted to Hospital Estadual Mário Covas and Hospital Anchieta from 2008 to 2012, with locally advanced breast cancer. Hormone receptor status, HER2 status, histologic and nuclear grade, age upon diagnosis and histological type of the tumor were analyzed. Pathologic evaluation of the tumor was subdivided into pathologic complete response, defined by the absence of tumor; intermediate response, considered as a favorable stage; and poor response, considering low-responder patients. Data obtained were submitted to statistical analysis. The study included 243 patients. There was an association of pathologic complete response with HER-2 negative, histological grade 3, stage III, hormone receptor negative, positive lymph node, older age and more advanced tumors. However, after multivariate analysis the only predictor of pathologic complete response was the presence of negative hormone receptor. By analyzing the prognostic factors, hormone receptor negative was considered as an independent risk factor, and pathologic complete response was considered as an independent protective factor. Hormone receptor negative is predictive of pathologic complete response and is an isolated risk factor for lower progression-free survival and overall survival. Pathologic complete response is a protective factor for these same survival analyses.